130 related articles for article (PubMed ID: 16334136)
1. Biological prognostic factors in adult soft tissue sarcomas.
Ottaiano A; De Chiara A; Fazioli F; Talamanca AA; Mori S; Botti G; Milano A; Apice G
Anticancer Res; 2005; 25(6C):4519-26. PubMed ID: 16334136
[TBL] [Abstract][Full Text] [Related]
2. Histological grading and MIB-1 labeling index of soft-tissue sarcomas.
Hasegawa T
Pathol Int; 2007 Mar; 57(3):121-5. PubMed ID: 17295643
[TBL] [Abstract][Full Text] [Related]
3. Should tumor depth be included in prognostication of soft tissue sarcoma?
Rydholm A; Gustafson P
BMC Cancer; 2003 May; 3():17. PubMed ID: 12769830
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of immunohistochemical expression of ezrin in highly malignant soft tissue sarcomas.
Weng WH; Ahlén J; Aström K; Lui WO; Larsson C
Clin Cancer Res; 2005 Sep; 11(17):6198-204. PubMed ID: 16144921
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of proliferation in pleomorphic soft tissue sarcomas: a new look at an old measure.
Seinen JM; Jönsson M; Bendahl PO; Baldetorp B; Rambech E; Åkerman M; Rydholm A; Nilbert M; Carneiro A
Hum Pathol; 2012 Dec; 43(12):2247-54. PubMed ID: 22789784
[TBL] [Abstract][Full Text] [Related]
6. Dysadherin expression as a significant prognostic factor and as a determinant of histologic features in synovial sarcoma: special reference to its inverse relationship with E-cadherin expression.
Izumi T; Oda Y; Hasegawa T; Nakanishi Y; Kawai A; Sonobe H; Takahira T; Kobayashi C; Yamamoto H; Tamiya S; Hirohashi S; Iwamoto Y; Tsuneyoshi M
Am J Surg Pathol; 2007 Jan; 31(1):85-94. PubMed ID: 17197923
[TBL] [Abstract][Full Text] [Related]
7. The management of adult soft tissue sarcomas.
Mendenhall WM; Indelicato DJ; Scarborough MT; Zlotecki RA; Gibbs CP; Mendenhall NP; Mendenhall CM; Enneking WF
Am J Clin Oncol; 2009 Aug; 32(4):436-42. PubMed ID: 19657238
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors for cutaneous and subcutaneous soft tissue sarcomas in dogs.
Dennis MM; McSporran KD; Bacon NJ; Schulman FY; Foster RA; Powers BE
Vet Pathol; 2011 Jan; 48(1):73-84. PubMed ID: 21139143
[TBL] [Abstract][Full Text] [Related]
9. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma.
Brizel DM; Scully SP; Harrelson JM; Layfield LJ; Bean JM; Prosnitz LR; Dewhirst MW
Cancer Res; 1996 Mar; 56(5):941-3. PubMed ID: 8640781
[TBL] [Abstract][Full Text] [Related]
10. Association of argyrophilic nucleolar organizing regions, Ki-67, and proliferating cell nuclear antigen scores with histologic grade and survival in dogs with soft tissue sarcomas: 60 cases (1996-2002).
Ettinger SN; Scase TJ; Oberthaler KT; Craft DM; McKnight JA; Leibman NF; Charney SC; Bergman PJ
J Am Vet Med Assoc; 2006 Apr; 228(7):1053-62. PubMed ID: 16579784
[TBL] [Abstract][Full Text] [Related]
11. 'Telangiectatic' transformation in soft tissue sarcomas. a clinicopathology analysis of an aggressive feature of high-grade sarcomas.
Sternheim A; Jin X; Shmookler B; Jelinek J; Malawer MM
Ann Surg Oncol; 2008 Jan; 15(1):345-54. PubMed ID: 17940825
[TBL] [Abstract][Full Text] [Related]
12. Analysis of prognostic factors associated with injection-site sarcomas in cats: 57 cases (2001-2007).
Romanelli G; Marconato L; Olivero D; Massari F; Zini E
J Am Vet Med Assoc; 2008 Apr; 232(8):1193-9. PubMed ID: 18412533
[TBL] [Abstract][Full Text] [Related]
13. Undifferentiated sarcoma: does it exist? A clinicopathologic study of 7 pediatric cases and review of literature.
Alaggio R; Bisogno G; Rosato A; Ninfo V; Coffin CM
Hum Pathol; 2009 Nov; 40(11):1600-10. PubMed ID: 19647855
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of Wilms tumor gene (WT1) mRNA expression in soft tissue sarcoma.
Sotobori T; Ueda T; Oji Y; Naka N; Araki N; Myoui A; Sugiyama H; Yoshikawa H
Cancer; 2006 May; 106(10):2233-40. PubMed ID: 16607650
[TBL] [Abstract][Full Text] [Related]
15. Soft tissue sarcomas: research of prognostic factors and therapeutics scheme.
Montagnese A; Sturla M; Bruno I; Bracaglia R; Salgarello M; Seccia A; Farallo E
J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):219-22. PubMed ID: 16767935
[TBL] [Abstract][Full Text] [Related]
16. Superficial soft tissue sarcomas (S-STS): a study of 367 patients from the French Sarcoma Group (FSG) database.
Salas S; Stoeckle E; Collin F; Bui B; Terrier P; Guillou L; Trassard M; Ranchere-Vince D; Gregoire F; Coindre JM
Eur J Cancer; 2009 Aug; 45(12):2091-102. PubMed ID: 19351580
[TBL] [Abstract][Full Text] [Related]
17. KIT activation in soft tissue sarcomas.
Tamborini E; Bonadiman L; Moiraghi L; Pilotti S; Pierotti MA
Am J Clin Pathol; 2002 Sep; 118(3):472-3; author reply 473. PubMed ID: 12219791
[No Abstract] [Full Text] [Related]
18. Re: Low-grade fibromyxoid sarcoma arising in the big toe.
Cabibi D
Pathol Int; 2007 Jul; 57(7):458; author reply 459-60. PubMed ID: 17587247
[No Abstract] [Full Text] [Related]
19. Significant clinical benefit of first-line palliative chemotherapy in advanced soft-tissue sarcoma: retrospective analysis and identification of prognostic factors in 488 patients.
Karavasilis V; Seddon BM; Ashley S; Al-Muderis O; Fisher C; Judson I
Cancer; 2008 Apr; 112(7):1585-91. PubMed ID: 18278813
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinase expression in high grade soft tissue sarcomas.
Alford SH; Vrana MS; Waite L; Heim-Hall J; Sylvia VL; Williams RP
Oncol Rep; 2007 Dec; 18(6):1529-36. PubMed ID: 17982640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
